Priti Desai
Ghandinagar, GJ 382426, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
EpiMix Based Novel Vaccine Candidate for Shigella: Evidence of Prophylactic Immunity in Balb/c Mice.
EpiMix Based Novel Vaccine Candidate for Shigella: Evidence of Prophylactic Immunity in Balb/c Mice.
Journal: International journal of peptide research and therapeutics
Published: December 21, 2020
Immunoinformatic Identification of Potential Epitopes.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 13, 2020
Oral immunization with LacVax® OmpA induces protective immune response against Shigella flexneri 2a ATCC 12022 in a murine model.
Journal: Vaccine
Published: February 21, 2018
In vivo delivery of pPERDBY to BALB/c mice by LacVax® DNA-I and comparison of elicited immune response with conventional immunization methods.
Journal: Gene therapy
Published: February 10, 2018
Dual recombinant Lactococcus lactis for enhanced delivery of DNA vaccine reporter plasmid pPERDBY.
Journal: Microbiology and immunology
Published: December 27, 2016
Shigellosis murine model established by intraperitoneal and intranasal route of administration: a comparative comprehension overview.
Journal: Microbes and infection
Published: April 01, 2016
Construction of a new shuttle vector for DNA delivery into mammalian cells using non-invasive Lactococcus lactis.
Journal: Microbes and infection
Published: September 09, 2015
Factors Affecting Inducible Expression of Outer Membrane Protein A (OmpA) of Shigella dysenteriae Type-1 in Lactococcus lactis Using Nisin Inducible Controlled Expression (NICE).
Journal: Indian journal of microbiology
Published: March 03, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026